Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous magnesium sulfate vs labetalol for bleeding and postoperative swelling in rhinoplasty
IRCT20211108053010N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in intraoperative bleeding, edema and ecchymosis comparing Intravenous magnesium sulfate with Intravenous labetalol (2 arms). Primary endpoints: Intraoperative bleeding volume, Postoperative edema and 1 more. Started May 2022; status: completed.
02
Drugs
magnesium sulfatelabetalol
03
Conditions
intraoperative bleedingedemaecchymosis
Beyond the preview
Go deeper on IRCT20211108053010N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211108053010N1.